Cognizant (CTSH) Tops Q2 EPS by 13c, Offers FY Guidance
Get Alerts CTSH Hot Sheet
Price: $59.29 +1.87%
Financial Fact:
Interest income: 27.2M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Interest income: 27.2M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cognizant (NASDAQ: CTSH) reported Q2 EPS of $0.82, $0.13 better than the analyst estimate of $0.69. Revenue for the quarter came in at $4 billion versus the consensus estimate of $3.84 billion.
GUIDANCE:
Cognizant sees FY2020 EPS of $3.48-$3.58, versus the consensus of $3.34. Cognizant sees FY2020 revenue of $16.4-16.7 billion, versus the consensus of $16.16 billion.
For earnings history and earnings-related data on Cognizant (CTSH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share